<?xml version="1.0" encoding="UTF-8"?>
<xml>
  <records>
    <record>
      <source-app name="Horizon">Horizon</source-app>
      <rec-number>1</rec-number>
      <foreign-keys>
        <key app="Horizon" db-id="fdi:010075538">1</key>
      </foreign-keys>
      <ref-type name="Journal Article">17</ref-type>
      <work-type>ACL : Articles dans des revues avec comité de lecture répertoriées par l'AERES</work-type>
      <contributors>
        <authors>
          <author>
            <style face="normal" font="default" size="100%">Dicker, D.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Golan, R.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Aron-Wisnewsky, J.</style>
          </author>
          <author>
            <style face="bold" font="default" size="100%">Zucker, Jean-Daniel</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Sokolowska, N.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Comaneshter, D. S.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Yahalom, R.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Vinker, S.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Clement, K.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Rudich, A.</style>
          </author>
        </authors>
      </contributors>
      <titles>
        <title>Prediction of long-term diabetes remission after rygb, sleeve gastrectomy, and adjustable gastric banding using DiaRem and Advanced-DiaRem scores</title>
        <secondary-title>Obesity Surgery</secondary-title>
      </titles>
      <pages>796-804</pages>
      <keywords>
        <keyword>Diabetes remission</keyword>
        <keyword>Bariatric surgery</keyword>
        <keyword>Prediction score</keyword>
      </keywords>
      <dates>
        <year>2019</year>
      </dates>
      <call-num>fdi:010075538</call-num>
      <language>ENG</language>
      <periodical>
        <full-title>Obesity Surgery</full-title>
      </periodical>
      <isbn>0960-8923</isbn>
      <accession-num>ISI:000462182400007</accession-num>
      <number>3</number>
      <electronic-resource-num>10.1007/s11695-018-3583-3</electronic-resource-num>
      <urls>
        <related-urls>
          <url>https://www.documentation.ird.fr/hor/fdi:010075538</url>
        </related-urls>
        <pdf-urls>
          <url>https://www.documentation.ird.fr/intranet/publi/2019/04/010075538.pdf</url>
        </pdf-urls>
      </urls>
      <volume>29</volume>
      <remote-database-provider>Horizon (IRD)</remote-database-provider>
      <abstract>Purpose DiaRem is a clinical scoring system designed to predict diabetes remission (DR) 1-year post-Roux-en-Y gastric bypass (RYGB). We examined long-term (2- and 5-year) postoperative DR prediction by DiaRem and an advanced-DiaRem (Ad-DiaRem) score following RYGB, sleeve gastrectomy (SG), and gastric banding (GB). Methods We accessed data from a computerized database of persons with type 2 diabetes and BMI &gt;= 30 kg/m(2) who underwent RYGB, SG, or GB, and determined DR status 2- and 5-year postoperative according to preoperative DiaRem and the Ad-DiaRem calculated scores. Results Among 1459 patients with 5-year postoperative diabetes status data, 53.6% exhibited DR. For RYGB, Ad-DiaRem trended to exhibit mildly improved predictive capacity 5-year postoperatively compared to DiaRem: Areas under receiver operating characteristic [AUROC] curves were 0.85 (0.76-0.93) and 0.78 (0.69-0.88), respectively. The positive predictive values (PPVs) detecting &gt;80% of those achieving DR (i.e., sensitivity &gt;= 0.8) were 78.2% and 73.2%, respectively, and higher Ad-DiaRem scores more consistently associated with decreased DR rates. Following SG, both scores had an AUROC of 0.82, but Ad-DiaRem still had a higher PPV for predicting &gt;80% of those with 5-year postoperative DR (76.2% and 71.0%). Predictive capacity parameters were comparatively lower, for both scores, when considering DR 5-year post-GB (AUROC: 0.73 for both scores, PPV: 66.3% and 64.3%, respectively). Conclusions Ad-DiaRem provides modest improvement compared to DiaRem in predicting long-term DR 5-years post-RYGB. Both scores similarly provide fair predictive capacity for 5-year postoperative DR after SG.</abstract>
      <custom6>054 ; 050</custom6>
      <custom1>UR209</custom1>
    </record>
  </records>
</xml>
